{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"Gemcitabine will be delivered as is standard of care. Patients diagnosed with pancreatic ductal carcinoma (PCD) will be treated with Gemcitabine and boosted once with the human childhood vaccine to TT\n\nGemcitabine: Gemcitabine will be administered on days 1, 8, 15 every 28 days\n\nTT vaccine booster: One human TT childhood vaccine booster will be administered on day 8","id":"OG000","title":"Gemcitabine With TT Vaccine Booster"}],"populationDescription":"MDSC data was not collected or analyzed for this study.","reportingStatus":"POSTED","timeFrame":"Day 8","title":"Change in Myeloid-derived Suppressor Cells","type":"OTHER_PRE_SPECIFIED"}